GENTA VIT
GENTA VIT
Authorised
- Biotin
- Folic acid
- Ascorbic acid
- VITAMIN B12
- VITAMIN B6
- D-PANTOTHENIC ACID
- Riboflavin
- Thiamine
- Nicotinic acid
- Menadione
- TOCOPHERYL ACETATE
- Colecalciferol
- Retinol
- Gentamicin sulfate
Product identification
Medicine name:
GENTA VIT
Active substance:
- Biotin
- Folic acid
- Ascorbic acid
- VITAMIN B12
- VITAMIN B6
- D-PANTOTHENIC ACID
- Riboflavin
- Thiamine
- Nicotinic acid
- Menadione
- TOCOPHERYL ACETATE
- Colecalciferol
- Retinol
- Gentamicin sulfate
Target species:
-
Pig
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Biotin0.50/milligram(s)100.00gram(s)
-
Folic acid1.50/milligram(s)100.00gram(s)
-
Ascorbic acid375.00/milligram(s)100.00gram(s)
-
VITAMIN B120.04/milligram(s)100.00gram(s)
-
VITAMIN B615.00/milligram(s)100.00gram(s)
-
D-PANTOTHENIC ACID38.00/milligram(s)100.00gram(s)
-
Riboflavin37.00/milligram(s)100.00gram(s)
-
Thiamine10.00/milligram(s)100.00gram(s)
-
Nicotinic acid190.00/milligram(s)100.00gram(s)
-
Menadione15.00/milligram(s)100.00gram(s)
-
TOCOPHERYL ACETATE10.00/gram(s)100.00gram(s)
-
Colecalciferol7500.00/international unit(s)100.00gram(s)
-
Retinol75000.00/international unit(s)100.00gram(s)
-
Gentamicin sulfate1.60/gram(s)100.00gram(s)
Pharmaceutical form:
-
Powder for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Pig
-
Meat and offal28day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA07AA91
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Farma Vet OOD
Marketing authorisation date:
Manufacturing sites for batch release:
- Farma Vet OOD
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1587
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 9/08/2022